Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Phase 1 Terminated

12 enrolled

DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

20 enrolled

Other solid neoplasm

Solid Tumor

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

37 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Phase 1 Terminated

157 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT05100251 2026-02-17

Clinical Trial of WBC100 on Advanced Solid Tumor

Phase 1 Terminated

68 enrolled

Other solid neoplasm

Solid Tumor

NCT05638334 2026-02-17

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Phase 1 Terminated

3 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06331559 2026-02-09

Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors

Phase 1 Terminated

13 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04166734 2026-02-04

MESO-PRIME

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

NCT05756907 2026-02-03

Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer

Phase 1/2 Terminated

40 enrolled

GynecologicOther solid neoplasm

Advanced Solid Tumor

NCT06771921 2026-01-30

A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors

Phase 1/2 Terminated

3 enrolled

Other solid neoplasm

Malignant Solid Tumor

Clinical Trials

A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

SUMMIT-1

A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma

A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Clinical Trial of WBC100 on Advanced Solid Tumor

Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours

Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors

MESO-PRIME

Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer

A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors